Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea

被引：3
|
作者：
Petty, Amy J. [1 ]
Emge, Drew A. [1 ]
Blanchard, Sarah K. [1 ]
Selim, Maria Angelica [2 ]
Scoggins, Kim [1 ]
Liu, Beiyu [3 ]
Green, Cynthia L. [3 ]
Cardones, Adela R. [4 ,5 ]
机构：
[1] Duke Univ, Dept Dermatol, Durham, NC USA
[2] Duke Univ, Dept Pathol, Div Dermatopathol, Durham, NC USA
[3] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[4] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS USA
[5] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 02期
关键词：
clinical trial; crisaborole; fibrosis; morphea; PDE4; CHILDREN; SAFETY;
D O I：
10.1016/j.jaad.2023.03.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：390 / 392
页数：3
相关论文
共 50 条
  • [41] Efficacy of lacosamide add-on therapy on Refractory Focal Epilepsies in children and adolescents: An open-label clinical trial
    Mohammadi, Tayebeh
    Nasiri, Jafar
    Ghazavi, Mohammad
    Yaghini, Omid
    Hoseini, Neda
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2022, 11 (03) : 109 - 115
  • [42] Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study
    Singh, Ankita
    Sarangi, Aditya N.
    Goel, Amit
    Srivastava, Rajni
    Bhargava, Rajat
    Gaur, Priyanka
    Aggarwal, Amita
    Aggarwal, Rakesh
    BMC GASTROENTEROLOGY, 2018, 18
  • [43] Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study
    Tsai, T. F.
    Liu, M. T.
    Liao, Y. H.
    Licu, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (03) : 345 - 352
  • [44] Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
    Mathew, Georgie
    Sinha, Aditi
    Ahmed, Aijaz
    Grewal, Neetu
    Khandelwal, Priyanka
    Hari, Pankaj
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2022, 37 (12) : 3117 - 3126
  • [45] Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers
    Armstrong, David G.
    Orgill, Dennis P.
    Galiano, Robert
    Glat, Paul M.
    Carter, Marissa
    Zelen, Charles M.
    Li, William W.
    INTERNATIONAL WOUND JOURNAL, 2020, 17 (05) : 1366 - 1375
  • [46] The efficacy of imiquimod 5% cream (Aldara®) in the treatment of aural plaque in horses: a pilot open-label clinical trial
    Torres, Sheila M. F.
    Malone, Erin D.
    White, Stephen D.
    Koch, Sandra N.
    Watson, Johanna L.
    VETERINARY DERMATOLOGY, 2010, 21 (05) : 503 - 509
  • [47] An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid
    Chen, Jun-Yi
    Feng, Qing-Lan
    Pan, Hui-Hui
    Zhu, Ding-Heng
    He, Ren-Liang
    Deng, Cheng-Cheng
    Yang, Bin
    DERMATOLOGY, 2023, 239 (05) : 818 - 827
  • [48] Camrelizumab Plus Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: A Single-Arm, Open-Label, Phase II Trial
    Mei, Qian
    Zhang, Wenying
    Liu, Yang
    Yang, Qingming
    Rasko, John E. J.
    Nie, Jing
    Liu, Jiejie
    Li, Xiang
    Dong, Liang
    Chen, Meixia
    Zhang, Yan
    Shi, Lu
    Wu, Huitao
    Han, Weidong
    CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4521 - 4530
  • [49] Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
    Zhang, Changgong
    Chen, Jianhua
    Wu, Huijuan
    Wang, Jun
    Gao, Liying
    Zhao, Jun
    Sun, Yan
    Jia, Zhongyao
    Mu, Xinlin
    Bai, Chunmei
    Wang, Rui
    Wu, Kailiang
    Liu, Qiang
    Shi, Yuankai
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (04): : 268 - 275
  • [50] Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
    Necchi, A.
    Lo Vullo, S.
    Giannatempo, P.
    Raggi, D.
    Calareso, G.
    Togliardi, E.
    Crippa, F.
    Pennati, M.
    Zaffaroni, N.
    Perrone, F.
    Busico, A.
    Colecchia, M.
    Nicolai, N.
    Mariani, L.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1346 - 1351
12345